Amdocs (NASDAQ:DOX) Releases Quarterly Earnings Results, Misses Estimates By $0.19 EPS

Amdocs (NASDAQ:DOX) posted its earnings results on Tuesday. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.64 by ($0.19), Zacks reports. Amdocs had a return on equity of 18.69% and a net margin of 9.85%. Amdocs updated its Q2 2025 guidance to 1.670-1.730 EPS and its FY 2025 guidance to 6.859-7.116 EPS.

Amdocs Stock Down 0.6 %

DOX stock opened at $86.86 on Wednesday. Amdocs has a twelve month low of $74.41 and a twelve month high of $94.04. The company has a market cap of $9.81 billion, a price-to-earnings ratio of 20.49, a P/E/G ratio of 1.47 and a beta of 0.71. The company has a quick ratio of 1.20, a current ratio of 1.20 and a debt-to-equity ratio of 0.21. The business has a 50 day moving average price of $85.96 and a two-hundred day moving average price of $86.40.

Amdocs Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Tuesday, December 31st were given a $0.479 dividend. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.21%. The ex-dividend date was Tuesday, December 31st. Amdocs’s dividend payout ratio is currently 45.28%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. Barclays lowered their price objective on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a research report on Thursday, November 14th. Oppenheimer boosted their price target on Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. Finally, StockNews.com lowered Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, January 14th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, Amdocs presently has a consensus rating of “Moderate Buy” and a consensus target price of $101.20.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.